Crinetics Pharmaceuticals Statistics

Total Valuation

CRNX has a market cap or net worth of $3.12 billion. The enterprise value is $1.90 billion.

Market Cap	3.12B
Enterprise Value	1.90B

Important Dates

The last earnings date was Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

CRNX has 93.68 million shares outstanding. The number of shares has increased by 37.21% in one year.

Current Share Class	93.68M
Shares Outstanding	93.68M
Shares Change (YoY)	+37.21%
Shares Change (QoQ)	+1.76%
Owned by Insiders (%)	1.48%
Owned by Institutions (%)	109.43%
Float	92.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4,107.13
Forward PS	622.42
PB Ratio	2.49
P/TBV Ratio	2.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2,497.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 22.53, with a Debt / Equity ratio of 0.04.

Current Ratio	22.53
Quick Ratio	22.36
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -30.84% and return on invested capital (ROIC) is -21.10%.

Return on Equity (ROE)	-30.84%
Return on Assets (ROA)	-20.13%
Return on Invested Capital (ROIC)	-21.10%
Return on Capital Employed (ROCE)	-28.89%
Revenue Per Employee	$1,739
Profits Per Employee	-$751,149
Employee Count	437
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.58% in the last 52 weeks. The beta is 0.32, so CRNX's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-30.58%
50-Day Moving Average	32.31
200-Day Moving Average	45.77
Relative Strength Index (RSI)	54.40
Average Volume (20 Days)	851,763

Short Selling Information

The latest short interest is 9.84 million, so 10.50% of the outstanding shares have been sold short.

Short Interest	9.84M
Short Previous Month	9.63M
Short % of Shares Out	10.50%
Short % of Float	10.66%
Short Ratio (days to cover)	8.73

Income Statement

In the last 12 months, CRNX had revenue of $760,000 and -$328.25 million in losses. Loss per share was -$3.82.

Revenue	760,000
Gross Profit	-262.30M
Operating Income	-376.73M
Pretax Income	-258.54M
Net Income	-328.25M
EBITDA	-373.49M
EBIT	-376.73M
Loss Per Share	-$3.82

Full Income Statement

Balance Sheet

The company has $1.27 billion in cash and $50.82 million in debt, giving a net cash position of $1.22 billion or $13.06 per share.

Cash & Cash Equivalents	1.27B
Total Debt	50.82M
Net Cash	1.22B
Net Cash Per Share	$13.06
Equity (Book Value)	1.25B
Book Value Per Share	13.41
Working Capital	1.23B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$261.57 million and capital expenditures -$3.75 million, giving a free cash flow of -$265.32 million.

Operating Cash Flow	-261.57M
Capital Expenditures	-3.75M
Free Cash Flow	-265.32M
FCF Per Share	-$2.83

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-49,569.74%
Pretax Margin	-43,191.05%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRNX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.21%
Shareholder Yield	-37.21%
Earnings Yield	-10.52%
FCF Yield	-8.50%

Analyst Forecast

The average price target for CRNX is $73.36, which is 120.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$73.36
Price Target Difference	120.17%
Analyst Consensus	Strong Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	310.49%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CRNX has an Altman Z-Score of 21.89 and a Piotroski F-Score of 2.

Altman Z-Score	21.89
Piotroski F-Score	2